Preventative Screening and Health Coaching in a Food Insecure Population
HEALTHCOACH
Community-Based Preventative Cardiometabolic Screening and Health Coaching- A Prospective Study
2 other identifiers
interventional
200
1 country
1
Brief Summary
The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are:
- Does longitudinal, individualized health coaching directed at lifestyle modification reduce patient 10-year risk of heart attack or stroke?
- Does longitudinal, individualized health coaching directed at lifestyle modification reduce rates of hypertension, hyperlipidemia, and diabetes?
- Does longitudinal, individualized health coaching directed at lifestyle modification improve accessibility to healthcare? Researchers will investigate the effects of regularly scheduled health coaching sessions on composite cardiometabolic risk profile as well as individual modifiable cardiovascular risk factors. Participants will:
- Participate in in-person cardiovascular screening, occuring at the time of enrollment, months 3 and 6.
- Engage in virtual health coaching sessions to talk about diet, exercise, weight loss, blood pressure and diabetes control, and accessibility to healthcare
- Keep a log of their blood pressure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedFirst Posted
Study publicly available on registry
April 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
April 2, 2025
March 1, 2025
2 years
March 26, 2025
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
10 - Year Atherosclerotic Cardiovascular Disease Risk Score
Study data collected during in-person screening - occuring at the initial screening, 3 and 6 month rescreening - will be utilized to calculate the patient's 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk via the MD+ Calc ASCVD risk calculator from the American Heart Association (AHA)/American College of Cardiology (ACC).
From enrollment to the end of study participation at 6 months.
Secondary Outcomes (9)
Depression - Patient Health Questionnaire - 2 (PHQ2)
From enrollment to the end of study participation at 6 months.
Sleep Apnea - STOP-BANG
From enrollment to the end of study participation at 6 months.
Point-of-care Hemoglobin A1c
From enrollment to the end of study participation at 6 months.
Point-of-care Blood Lipid Level
From enrollment to the end of study participation at 6 months.
Blood Pressure
From enrollment to the end of study participation at 6 months.
- +4 more secondary outcomes
Study Arms (1)
Intervention
EXPERIMENTALPatients will receive health coaching sessions, conducted by medical students and overseen by a licensed health coach, directed at individualized lifestyle modification relevant to the patient's cardiometabolic health profile. Patients will receive blood pressure cuffs and will be instructed as to how to measure and keep a log of their blood pressure to be reviewed during health coaching sessions. Sessions will occur biweekly for 1 month followed by the next 2 months. Sessions will last approximately 15 minutes in length. Objective data including blood pressure, point-of-care lipid panel and hemoglobin A1c, 10-year atherosclerotic cardiovascular disease (ASCVD) risk score, as well as surveys regarding depression, sleep apnea, physical activity, social determinants of health, and health literacy will be conducted at the time of study enrollment and at 3 and 6 months of study participation.
Interventions
During in-person events and screening - occurring at the initial screening, 3, and 6 months - patients will receive individualized health coaching by on-site physicians and nurse practitioners specializing in lifestyle medicine. Patients will receive virtual health coaching sessions, conducted by medical students and overseen by a licensed health coach, directed at individualized lifestyle modification relevant to the patient's cardiometabolic health profile. Interventions will include but not limited to: changes in diet, exercise, smoking, and drinking status. Patients will receive blood pressure cuffs and will be instructed as to how to measure and keep a log of their blood pressure to be reviewed during health coaching sessions. Sessions will occur biweekly for the first month and monthly for the following 2 months. Sessions will last approximately 15 minutes in length.
Eligibility Criteria
You may qualify if:
- Patient is a participant at a CHI sponsored, community screening event Patient provides informed consent and willingness to participate for the duration of the study English or Spanish speaking Age 40-75 years old At least 1 cardiometabolic risk factor at suboptimal level
- Defined as one or more of the following at initial screening:
- Blood Pressure (BP):
- Systolic BP greater than 130mmHg and/or diastolic BP greater than 80mmHg. Obesity: body mass index (BMI) greater than 30 〖kg/m〗\^2
- Dyslipidemia:
- Total cholesterol greater than 200 mg/dL Triglycerides greater than 150 mg/dL Low density lipoprotein (LDL) greater than 130 mg/dL High density lipoprotein (HDL) less than 40 mg/dL in men or less than 50 mg/dL in women Hemoglobin A1c greater than or equal to 5.7% 10-year ASCVD score greater than 5% Access to a telehealth compatible device
You may not qualify if:
- Adults unable to provide informed consent or unwilling to participate for study duration Speaks language other than English or Spanish Younger than 40 years old or older than 75 years old All cardiometabolic risk factors at optimal levels No telehealth compatible device Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rush University Medical Centerlead
- The Physicians' Foundationcollaborator
Study Sites (1)
Rush University Medical Center
Chicago, Illinois, 60612, United States
Related Publications (15)
Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR; Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003 Apr 23-30;289(16):2083-93. doi: 10.1001/jama.289.16.2083.
PMID: 12709466BACKGROUNDSoltani D, Azizi B, Behnoush AH, Meysamie A, Aein A, Nayebirad S, Vasheghani-Farahani A, Akbari Sari A. Is lifestyle modification with individual face-to-face education and counseling more effective than usual care for controlling hypertension? A systematic review and meta-analysis of randomized controlled trials. Health Educ Res. 2023 Sep 20;38(5):490-512. doi: 10.1093/her/cyad028.
PMID: 37450326BACKGROUNDMa C, Zhou Y, Zhou W, Huang C. Evaluation of the effect of motivational interviewing counselling on hypertension care. Patient Educ Couns. 2014 May;95(2):231-7. doi: 10.1016/j.pec.2014.01.011. Epub 2014 Jan 30.
PMID: 24530144BACKGROUNDNakano M, Eguchi K, Sato T, Onoguchi A, Hoshide S, Kario K. Effect of Intensive Salt-Restriction Education on Clinic, Home, and Ambulatory Blood Pressure Levels in Treated Hypertensive Patients During a 3-Month Education Period. J Clin Hypertens (Greenwich). 2016 May;18(5):385-92. doi: 10.1111/jch.12770. Epub 2016 Jan 6.
PMID: 26732187BACKGROUNDSeguin-Fowler RA, Strogatz D, Graham ML, Eldridge GD, Marshall GA, Folta SC, Pullyblank K, Nelson ME, Paul L. The Strong Hearts, Healthy Communities Program 2.0: An RCT Examining Effects on Simple 7. Am J Prev Med. 2020 Jul;59(1):32-40. doi: 10.1016/j.amepre.2020.01.027. Epub 2020 May 7.
PMID: 32389532BACKGROUNDKoniak-Griffin D, Brecht ML, Takayanagi S, Villegas J, Melendrez M, Balcazar H. A community health worker-led lifestyle behavior intervention for Latina (Hispanic) women: feasibility and outcomes of a randomized controlled trial. Int J Nurs Stud. 2015 Jan;52(1):75-87. doi: 10.1016/j.ijnurstu.2014.09.005. Epub 2014 Sep 22.
PMID: 25307195BACKGROUNDKitzman H, Mamun A, Dodgen L, Slater D, King G, King A, Slater JL, DeHaven M. Better Me Within Randomized Trial: Faith-Based Diabetes Prevention Program for Weight Loss in African American Women. Am J Health Promot. 2021 Feb;35(2):202-213. doi: 10.1177/0890117120958545. Epub 2020 Sep 18.
PMID: 32945175BACKGROUNDBuchanan Z, Hopkins SE, Ryman TK, Austin MA, Wiener HW, Tiwari HK, Klejka JA, Boyer BB, Fohner AE. Electronic health record reveals community-level cardiometabolic health benefits associated with 10 years of community-based participatory research. Public Health. 2024 Jul;232:38-44. doi: 10.1016/j.puhe.2024.04.010. Epub 2024 May 10.
PMID: 38733959BACKGROUNDLiu Y, Eicher-Miller HA. Food Insecurity and Cardiovascular Disease Risk. Curr Atheroscler Rep. 2021 Mar 27;23(6):24. doi: 10.1007/s11883-021-00923-6.
PMID: 33772668BACKGROUNDKris-Etherton PM, Petersen KS, Velarde G, Barnard ND, Miller M, Ros E, O'Keefe JH, Williams K Sr, Horn LV, Na M, Shay C, Douglass P, Katz DL, Freeman AM. Barriers, Opportunities, and Challenges in Addressing Disparities in Diet-Related Cardiovascular Disease in the United States. J Am Heart Assoc. 2020 Apr 7;9(7):e014433. doi: 10.1161/JAHA.119.014433. Epub 2020 Mar 23.
PMID: 32200727BACKGROUNDPowell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT, Pita MA, Potharaju KA, Tamura K, Wallen GR. Social Determinants of Cardiovascular Disease. Circ Res. 2022 Mar 4;130(5):782-799. doi: 10.1161/CIRCRESAHA.121.319811. Epub 2022 Mar 3.
PMID: 35239404BACKGROUNDShahu A, Okunrintemi V, Tibuakuu M, Khan SU, Gulati M, Marvel F, Blumenthal RS, Michos ED. Income disparity and utilization of cardiovascular preventive care services among U.S. adults. Am J Prev Cardiol. 2021 Nov 6;8:100286. doi: 10.1016/j.ajpc.2021.100286. eCollection 2021 Dec.
PMID: 34816144BACKGROUNDKim YJ, Kim S, An J, Volgman AS, Nazir NT. Impact of the COVID-19 pandemic on cardiovascular disease mortality in a major metropolitan area. Am Heart J Plus. 2022 Jun;18:100173. doi: 10.1016/j.ahjo.2022.100173. Epub 2022 Jul 13.
PMID: 35856067BACKGROUNDWoodruff RC, Tong X, Khan SS, Shah NS, Jackson SL, Loustalot F, Vaughan AS. Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010-2022. Am J Prev Med. 2024 Apr;66(4):582-589. doi: 10.1016/j.amepre.2023.11.009. Epub 2023 Nov 14.
PMID: 37972797BACKGROUNDAhmad FB, Anderson RN. The Leading Causes of Death in the US for 2020. JAMA. 2021 May 11;325(18):1829-1830. doi: 10.1001/jama.2021.5469. No abstract available.
PMID: 33787821BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Luger, MD
Rush University Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairman of Medicine, Rush Oak Park, Cardiovascular Prevention and Clinical Lipidology, Division of Cardiology
Study Record Dates
First Submitted
March 26, 2025
First Posted
April 2, 2025
Study Start
April 1, 2025
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
April 2, 2025
Record last verified: 2025-03